FDA Inspection
Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals, Inc. – FDA Inspection, Jul 27, 2018
Record Details
This FDA Inspection record concerns Catalyst Pharmaceuticals, Inc., with an inspection on July 27, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f1d5f2b5-b8b0-43ab-9c69-c75aecb9f6ce
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1061547
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Catalyst Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 22, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Catalyst Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.